Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2007
11/14/2007EP1854472A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same
11/14/2007EP1854471A1 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/14/2007EP1853707A2 Uses of il-23 antagonists in the treatment of diabetes mellitus
11/14/2007EP1853606A1 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs
11/14/2007EP1853585A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters
11/14/2007EP1853579A2 2-substituted 5-membered heteroaryl carboxylates as hm74a receptor agonists
11/14/2007EP1853570A2 Hsp90-inhibiting triazole derivatives
11/14/2007EP1853566A1 Cinnoline compounds and their use as liver x receptor modulators
11/14/2007EP1853556A1 Derivatives of aminobutanoic acid inhibiting cpt
11/14/2007EP1853555A1 Anthranilic acid derivatives active at the hm74a receptor
11/14/2007EP1853552A2 Diastereoisomers of 4-hydroxyisoleucine and uses thereof
11/14/2007EP1853266A1 Methods and compositions for treating diabetes, metabolic syndrome and other conditions
11/14/2007EP1853263A1 Compositions and methods for treating dyslipidemia
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1696909B1 Benzothiazole derivatives for the treatment of diabetes
11/14/2007EP1578745B1 BENZOFURAN DERIVATivES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES THEREOF
11/14/2007EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1413309B1 Drugs for ameliorating postcibal hyperglycemia
11/14/2007EP1296740B1 Delivery of a substance into the dermis
11/14/2007EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007EP1212086B1 Immunological tolerance-induction agent
11/14/2007EP1181042B1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1053011B1 Mixed micellar pharmaceutical delivery system and method of preparation
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007CN101072757A Benzamide derivatives that act upon the glucokinase enzyme
11/14/2007CN101070328A (E)3,5-di-methoxy-diphenylene-4'-0-phosphates (salt) and its preparing method, medicine composition and use
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN101069742A Pancreatic kininogenase tablet and preparing method
11/14/2007CN101069737A Chinese herbal medicine oral liquor for reducing humanbody cholesterin and regulating blood-fat and clearing intestines and relaxing the bowels
11/14/2007CN101069731A Ready-made Chinese medicine jelly-pills for treating hypertension
11/14/2007CN101069730A Chinese medicine preparation for spleen-tonifying nourishing-Qi, kidney-tonifying and bone-strengthening and preparing method
11/14/2007CN101069719A Selenium-rich tea pigment extracting technology
11/14/2007CN101069710A Compounded medicine for preventing and treating metabolic syndrome and hyperlimemia
11/14/2007CN101069709A Nutrient health-care capsule
11/14/2007CN101069707A Herba polygonic avicularis total flavones and its preparing method and medicine use
11/14/2007CN101069684A Composition comprising a cholesterol absorption inhibitor, and hmg-coa reductase inhibitor and a stabilizing agent
11/14/2007CN101069571A Pine-pollen-leave drink and preparing method
11/14/2007CN101069563A Drink composition for preventing decomposition of vitamin in drink, and method therefor
11/14/2007CN101069560A Jinpuqi cold tea
11/14/2007CN101069559A Ganoderma-lucidum grain lotus-seed-heart powder
11/14/2007CN101069557A Health-care blood-sugar-reducing food and preparing method
11/14/2007CN101069556A Fat-reducing food
11/14/2007CN101069555A Kudzuvine root areca and making method
11/14/2007CN101069552A Method for preparing ageratum and purple common perilla fish-jam
11/14/2007CN101069551A Method for preparing ageratum and elsholtzia type roasting jam
11/14/2007CN101069550A Ageratum compound seasoning and use of the same in stewing fish
11/14/2007CN101069546A Poria-cocos eight-treasures noodles and preparing method
11/14/2007CN101069535A Jinyangye green tea and its making method
11/14/2007CN100348609C Glucocorticoid receptor ligands for the treatment of metabolic disorders
11/14/2007CN100348604C Crystal of amido sugar
11/14/2007CN100348600C Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors
11/14/2007CN100348596C Indole-3-carboxamides as glucokinase(GK) activators
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348584C 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
11/14/2007CN100348251C Medicine for treating diabetes and its preparation method
11/14/2007CN100348236C Medicine for treating diabetes
11/14/2007CN100348224C Chinese medicinal capsule used for reducing blood fat, its preparation method and use
11/14/2007CN100348220C Chinese materia medica preparation for treating diabetic nephropathy, and preparation method
11/14/2007CN100348203C Hypercritical soluble propolis prescription and its preparing method
11/14/2007CN100348201C Methy cobalamine dispersion tablet and preparing method
11/14/2007CN100348191C Gynostemma pentaphylla tolal glucoside dripping pills and its prepn. method
11/14/2007CN100348189C Combination of an dpp-iv inhibitor and a ppar-alpha compound
11/14/2007CN100348186C Compounds for the treatment of metabolic disorders
11/14/2007CN100348129C Nutrient solution strengthening the body of children, and preparation method
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294698 An isolated Archipelin polypeptide
11/13/2007US7294652 Autoimmune conditions and NADPH oxidase defects
11/13/2007US7294644 CB 1 receptor inverse agonists
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294626 4-(6-(p-substituted phenyl)-3-pyridazinyl)-1-isopropylpiperazines, e.g., 4-[6-(4-Isopropylpiperazin-1-yl)-pyridazin-3-yl]benzonitrile; treatment of diseases or disorders related to the histamine H3 receptor, e.g., obesity, eating disorders, osteoarthritis, type 2 diabetes, allergic rhinitis, & narcolepsy
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294618 Glucopyranosyloxypyrazole derivatives and medicinal use thereof
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294475 Gene and use thereof
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007CA2383715C Improving condition of elderly pets
11/13/2007CA2362968C Fat based food products
11/13/2007CA2352544C Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
11/13/2007CA2345006C New benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmaceutical compositions
11/13/2007CA2342804C Vending machine
11/13/2007CA2241171C Product derived from milk substantially free of beta casein from non-human mammals and relative use
11/13/2007CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
11/13/2007CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/08/2007WO2007127901A1 Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127765A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127763A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127726A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127704A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127693A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127688A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127502A2 Polymorphic form of { 2-methyl-4- [ 4-methyl-2- ( 4-triflu0r0methylphenyl) thiazol -5- ylmethylthiol phenoxy }-acetic acid
11/08/2007WO2007127408A2 Methods for treating diabetes
11/08/2007WO2007127382A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
11/08/2007WO2007126993A2 Multi-membrane immunoisolation system for cellular transplant
11/08/2007WO2007126792A2 Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases
11/08/2007WO2007126358A1 Diphenylazetidinone derivates possessing cholesterol absor tion inhibitor activit.